world
health
organ
estim
half
million
new
case
childhood
tuberculosi
tb
occur
everi
year
annual
mortal
childhood
tb
account
tb
case
worldwid
case
high
tb
burden
countri
tb
progress
rapidli
children
immatur
immun
system
rapid
detect
tb
children
enabl
rapid
treatment
improv
outcom
current
avail
tb
test
perform
poorli
children
pulmonari
tb
adult
diagnos
smear
cultur
molecular
test
perform
expector
sputum
howev
children
often
unabl
expector
sputum
volum
qualiti
need
sputumbas
diagnost
consequ
sputum
smear
cultur
mycobacterium
tuberculosi
mtb
often
neg
children
tb
childhood
tb
also
diagnos
test
earli
morn
gastric
aspir
howev
procedur
invas
diagnost
yield
gastric
aspir
rang
children
therefor
often
treat
empir
tb
base
clinic
featur
chest
xray
find
tuberculin
skin
test
contact
index
patient
approach
may
lead
treatment
furthermor
lack
bacteriolog
cultur
confirm
make
imposs
test
drug
resist
diseas
factor
creat
urgent
need
develop
rapid
sensit
test
detect
tb
test
drug
resist
children
stool
promis
sampl
matrix
pediatr
tb
test
mtb
may
swallow
pass
child
stool
easili
sampl
mtb
difficult
routin
cultur
stool
rapidli
grow
bacteria
may
overgrow
slowli
replic
tuberculosi
bacillu
nucleic
acid
base
amplif
test
naat
detect
mtb
stool
good
sensit
xpert
mtbrif
xpert
assay
cepheid
sunnyval
ca
recommend
detect
tb
sputum
also
exploit
extrapulmonari
sampl
previou
tb
detect
studi
perform
stool
xpert
assay
detect
mtb
sensit
specif
howev
stool
process
protocol
requir
centrifug
would
suitabl
point
care
test
resourcelimit
environ
xpert
stool
test
also
gener
unaccept
larg
number
error
probabl
sampl
clog
xpert
assay
cartridg
due
pcr
inhibit
stool
compon
poor
sensit
report
xpert
stool
studi
could
due
retain
pcr
inhibitor
may
also
due
low
amount
sampl
test
g
assay
sensit
could
increas
method
avail
test
larger
quantiti
stool
without
introduc
pcr
inhibitor
present
novel
method
process
larger
volum
stool
specimen
direct
detect
mtb
use
xpert
assay
approach
valid
pediatr
stool
sampl
tb
case
control
tuberculosi
mtb
strain
obtain
american
type
cultur
collect
atcc
manassa
va
cultur
quantifi
plate
coloni
form
unit
cfu
middlebrook
agar
plate
bd
franklin
lake
nj
bovi
bcg
pasteur
strain
use
surrog
mtb
prequantifi
frozen
mtb
bcg
cell
stock
sonic
vortex
vigor
min
make
serial
dilut
middlebrook
media
bd
dilut
seri
analyt
spike
studi
stool
obtain
unit
state
human
subject
suspect
tb
stool
cynomolgu
n
macaca
fasciculari
rhesu
macaqu
n
macaca
mulatta
activ
pulmonari
tb
induc
intrabronchi
infect
mtb
strain
erdman
uninfect
control
cynomolgu
macaqu
n
freshli
collect
store
overnight
transport
ice
pack
stool
indic
process
follow
protocol
describ
fig
two
ml
stool
process
buffer
spb
contain
al
buffer
qiagen
valencia
ca
polyvinylpyrrolidon
sigma
aldrich
st
loui
mo
two
ml
xpert
mtbrif
sampl
reagent
sr
cepheid
mm
glass
bead
fisher
scientif
pittsburgh
pa
ad
mixtur
final
stool
buffer
combin
mix
snap
vortex
second
incub
min
room
temperatur
pass
syring
filter
fit
glass
wool
captur
stool
debri
clean
collect
vial
fig
two
ml
filtrat
load
sampl
load
chamber
xpert
assay
cartridg
subsequ
sampl
process
pcr
perform
accord
manufactur
recommend
use
cartridg
genexpert
instrument
ver
onegram
human
tb
neg
stool
spike
five
differ
concentr
bovi
bcg
cfug
six
differ
concentr
mtb
strain
cell
cfug
tb
neg
stool
use
neg
control
concentr
zero
experi
stool
treat
accord
sampleprocess
protocol
describ
fig
total
four
replic
per
cfu
concentr
lod
defin
lowest
cfu
concentr
produc
posit
result
valid
studi
fresh
stool
sampl
tb
posit
control
conduct
kwazulunat
research
institut
tb
hiv
krith
children
year
old
recruit
januari
januari
hospit
clinic
within
ethekwini
region
durban
kwazulunat
south
africa
sampl
taken
two
group
tb
case
children
confirm
tb
posit
xpert
mtbrif
induc
sputum
gastric
lavag
tbneg
control
children
symptom
sign
suggest
childhood
tb
neg
xpert
mtbrif
test
induc
sputum
gastric
lavag
sputum
cultur
consid
enrol
criteria
studi
subject
xpert
cultur
test
perform
tb
case
sourc
case
file
result
obtain
nation
health
laboratori
servic
nhl
genexpert
laboratori
durban
revers
trace
document
result
tbneg
control
sourc
primari
health
care
clinic
hospit
particip
exclud
five
day
empir
antituberculosi
treatment
past
month
parent
inform
consent
unattain
child
assent
particip
year
age
unattain
evid
extrapulmonari
tb
particip
withdrawn
studi
inadequ
stool
volum
produc
particip
follow
recruit
sampl
collect
clinic
characterist
shown
tabl
collect
particip
report
chart
review
tb
case
definit
use
tabl
primari
data
analysi
conform
nation
standard
follow
definit
tb
diseas
least
one
sign
symptom
suggest
tb
diseas
microbiolog
confirm
mtb
probabl
tb
diseas
least
one
sign
symptom
suggest
tb
diseas
chest
radiograph
consist
intrathorac
tb
diseas
presenc
one
follow
posit
clinic
respons
tb
treatment
b
document
exposur
sourc
case
tb
diseas
c
immunolog
evid
tb
infect
possibl
tb
diseas
least
one
sign
symptom
suggest
tb
diseas
either
clinic
respons
tb
treatment
document
exposur
sourc
case
tb
diseas
immunolog
evid
tb
infect
b
chest
radiographi
consist
intrathorac
tb
diseas
note
studi
purpos
standard
clinic
tb
case
definit
includ
result
molecular
test
includ
xpert
mtbrif
one
stool
sampl
collect
particip
time
bowel
motion
sampl
consist
relationship
meal
water
intak
previou
hour
note
first
stool
pass
day
collect
tb
case
neg
control
sampl
store
maximum
one
week
test
laboratori
test
perform
steril
hood
biosafeti
laboratori
accord
standard
oper
procedur
describ
fig
studi
approv
univers
medicin
dentistri
new
jersey
umdnj
institut
review
board
irb
becam
rutger
univers
irb
upon
merger
umdnj
rutger
juli
protocol
biomed
ethic
research
committe
brec
univers
kwazulunat
protocol
kwazulu
natal
depart
health
protocol
hrkm
written
consent
letter
particip
also
approv
brec
protocol
hrkm
particip
without
written
consent
exclud
studi
document
save
investig
un
fk
comput
nonhuman
primat
stool
sampl
use
studi
obtain
anim
investig
anoth
purpos
iacuc
protocol
assur
number
specif
protocol
approv
number
stool
sampl
obtain
remov
anim
cage
slate
discard
experiment
manipul
protocol
care
anim
parent
studi
approv
univers
pittsburgh
school
medicin
institut
anim
care
use
committe
iacuc
iacuc
adher
nation
guidelin
establish
anim
welfar
act
usc
section
guid
care
use
laboratori
anim
edit
mandat
us
public
health
servic
polici
monkey
hous
univers
pittsburgh
region
biocontain
center
anim
facil
mo
collect
stool
monkey
cage
pan
time
collect
none
monkey
treatment
author
mjo
jlf
physic
contact
monkey
standard
statist
analysi
averag
standard
deviat
ttest
perform
use
microsoft
excel
window
oneway
analysi
varianc
independ
correl
sampl
anova
carri
evalu
p
valu
use
onlin
anova
calcul
http
refer
standard
diagnosi
tb
xpert
induc
sputumgastr
lavag
result
sensit
defin
percent
result
posit
stool
result
genexpert
induc
sputum
gastric
aspir
posit
case
exact
confid
interv
specif
defin
percent
result
neg
result
among
control
patient
exact
confid
interv
twotail
fisher
exact
probabl
test
use
compar
tb
case
tb
control
use
onlin
calcul
http
studi
much
stool
sampl
ad
assay
provid
best
sensit
tb
detect
goal
introduc
maximum
amount
mtb
assay
without
degrad
pcr
perform
introduc
excess
pcr
inhibitor
spike
tb
neg
stool
bcg
final
concentr
cfug
sampl
process
use
optim
protocol
fig
test
xpert
assay
n
stool
weight
delay
cycl
threshold
ct
xpert
assay
intern
control
ic
indic
pcr
inhibit
ic
ct
valu
remain
averag
stool
quantiti
fig
suggest
stool
process
method
effect
elimin
pcr
inhibitor
amount
stool
studi
sampl
process
pressur
measur
genexpert
instrument
report
normal
softwar
significantli
affect
increas
stool
quantiti
p
consist
psi
approxim
onehalf
permit
pressur
limit
assay
fig
contrast
minimum
rpob
ct
decreas
sampl
compar
sampl
respect
p
fig
result
suggest
ad
increas
quantiti
process
stool
xpert
assay
improv
assay
sensit
mtb
detect
simul
human
patient
activ
tb
perform
addit
stool
quantiti
rang
studi
use
stool
collect
nine
macaqu
pulmonari
tb
five
uninfect
control
macaqu
stool
sampl
weigh
test
triplic
follow
protocol
fig
test
effect
sampl
differ
portion
stool
sampl
determin
increment
benefit
test
multipl
sampl
singl
stool
sampl
test
macaqu
stool
sampl
posit
tb
fig
two
stool
sampl
test
macaqu
stool
sampl
respect
posit
tb
final
three
stool
sampl
test
macaqu
stool
sampl
stool
sampl
stool
sampl
posit
tb
data
suggest
optim
quantiti
stool
assay
repeat
test
could
improv
assay
sensit
differ
percent
posit
rate
two
differ
macaqu
cynomolgu
vs
rhesu
uninfect
control
test
n
neg
method
also
observ
macaqu
stool
mani
physic
differ
human
stool
exampl
macaqu
stool
pellet
form
semisolid
consist
observ
human
stool
assay
lod
stool
evalu
spike
known
number
mtb
cfu
stool
specimen
fig
assay
lod
cfug
stool
bcg
mtb
mtb
also
detect
stool
sampl
spike
cfug
cfug
respect
fig
wherea
bcg
detect
stool
sampl
spike
cfug
fig
twenti
tb
case
tbneg
control
particip
enrol
clinic
studi
two
control
exclud
due
miss
data
fig
tabl
show
relev
clinic
laboratori
characterist
particip
tb
case
control
fit
definit
propos
intern
clinic
case
definit
intrathorac
tuberculosi
probabl
tb
sputum
mgit
cultur
result
posit
mtb
tb
case
cultur
neg
control
case
fit
definit
definit
tb
test
perform
stool
sampl
posit
tb
case
sensit
ci
tabl
test
perform
stool
sampl
posit
stool
tb
case
sensit
ci
tabl
sampl
exclud
due
probe
check
error
xpert
stool
assay
perform
sampl
detect
tb
particip
met
case
definit
posit
gastric
aspir
met
case
definit
posit
induc
sputum
test
perform
sampl
detect
tb
particip
met
case
definit
posit
gastric
aspir
met
case
definit
posit
induc
sputum
specif
assay
perform
stool
sampl
ci
specif
assay
perform
stool
sampl
ci
assay
posit
test
stool
sampl
particip
cultur
posit
mtb
sputum
three
particip
gastric
aspir
one
particip
post
hoc
subgroup
analysi
stool
assay
posit
hiv
posit
tb
case
hiv
neg
expos
neg
tb
case
hiv
children
expos
birth
subsequ
test
hiv
neg
tb
case
unknown
hiv
statu
assay
also
posit
tb
case
tb
treatment
day
tb
case
antituberculosi
therapi
four
tb
case
posit
cultur
induc
sputum
gastric
lavag
rifampin
rif
sensit
phenotyp
test
four
tb
case
also
found
rifampin
suscept
mtb
stool
assay
assay
perform
appear
affect
stool
color
consist
semiform
form
liquid
water
dietari
intak
hour
stool
collect
shown
simpl
protocol
buffer
set
use
process
stool
sampl
test
mtb
xpert
mtbrif
assay
method
includ
two
innov
compon
stool
process
buffer
spb
along
xpert
mtbrif
sampl
process
inactiv
pcr
inhibitor
allow
stool
easili
filter
filter
configur
permit
easi
filtrat
treat
stool
sampl
found
glass
wool
use
filter
stool
debri
effici
type
filter
materi
test
includ
cotton
whatman
filter
filter
pad
gauz
glass
filter
pad
treat
stool
sampl
spb
sr
pass
filter
describ
fig
result
invalid
tb
case
invalid
qc
probe
check
error
tb
case
invalid
caus
delay
absenc
cycl
threshold
ct
intern
control
ic
could
due
introduct
pcr
inhibitor
sampl
qc
probe
check
error
often
due
abnorm
signal
assay
compon
within
xpert
mtbrif
cartridg
multipl
caus
spite
error
perform
significantli
better
achiev
stool
process
method
even
though
method
complex
test
smaller
amount
stool
often
requir
addit
equip
permit
centrifug
often
difficult
achiev
firm
diagnosi
tuberculosi
children
exampl
least
two
induc
sputum
sampl
requir
achiev
sensit
singl
sputum
sampl
adult
tb
suspect
like
pediatr
tb
paucibacillari
lung
compar
adult
reason
paucibacillari
tb
would
easili
diagnos
test
larger
volum
stool
inde
studi
tb
infect
macaqu
stool
sampl
significantli
posit
stool
sampl
howev
find
stool
sampl
perform
better
stool
sampl
human
particip
even
though
test
one
stool
suggest
tb
neg
control
particip
tb
posit
sampl
tb
neg
particip
could
repres
fals
posit
diagnosi
could
repres
true
posit
particip
meet
diagnost
criteria
tb
particip
treat
clinic
tb
follow
studi
limit
small
sampl
size
sensit
specif
estim
wide
confid
interv
improv
assay
perform
larger
stool
size
could
easili
miss
given
limit
number
studi
particip
final
limit
facil
made
difficult
confirm
cultur
presenc
tb
particip
met
case
definit
tb
posit
previou
studi
howev
shown
xpert
mtbrif
assay
high
posit
predict
valu
compar
mtb
cultur
thu
like
studydefin
tb
case
truli
tb
approxim
children
high
burden
countri
develop
tb
molecular
diagnost
tool
xpert
mtbrif
promis
improv
diagnosi
tb
age
group
obtain
good
qualiti
respiratori
sampl
difficult
children
extrapulmonari
sampl
stool
may
easier
obtain
approach
may
therefor
significantli
improv
tb
detect
children
furthermor
adult
tb
suspect
produc
adequ
sputum
sampl
therefor
approach
may
also
use
older
age
group
modifi
approach
test
stool
sampl
xpert
mtbrif
system
one
aspect
tb
diagnosi
must
solv
permit
assay
easili
use
point
care
test
environ
exampl
current
genexpert
test
instrument
requir
laptop
comput
continu
power
sourc
howev
recent
announc
introduct
portabl
batteri
oper
unit
run
xpert
mtbrif
assay
genexpert
omni
http
wwwcepheidcomusgenexpertomni
may
resolv
barrier
point
care
test
conclus
effici
stool
sampl
process
method
develop
appear
simplifi
tb
detect
children
larger
clinic
studi
need
evalu
full
perform
paramet
potenti
impact
methodolog
